Implications of lower risk thresholds for statin treatment in primary prevention: Analysis of CPRD and simulation modelling of annual cholesterol monitoring-Reference-Cited by-同舟云学术

Implications of lower risk thresholds for statin treatment in primary prevention: Analysis of CPRD and simulation modelling of annual cholesterol monitoring

Published:2015-01 Issue: Volume:70 Page:14-16
ISSN:0091-7435
Container-title:Preventive Medicine
language:en
Short-container-title:Preventive Medicine

Author:

McFadden Emily,Stevens Richard,Glasziou Paul,Perera Rafael

Funder

Health Technology Assessment Programme

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Epidemiology

Reference22 articles.

1. Cardiovascular disease risk profiles;Anderson;Am. Heart J.,1991

2. Menopause, age, and cardiovascular risk: a complex relationship;Bittner;J. Am. Coll. Cardiol.,2009

3. Cooper, A., Nherera, L., Calvert, N., et al., 2010. Clinical Guidelines and Evidence Review for Lipid Modification: cardiovascular risk assessment and the primary and secondary prevention of cardiovascular disease, London: National Collaborating Centre for Primary Care and Royal College of General Practitioners. NICE, London.

4. Non-cardiovascular effects associated with statins;Desai;BMJ,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses;BMJ;2021-07-14

2. Diagnosis, Prognosis, Management, Treatment, Research and Advances in Canine Dilated Cardiomyopathy;Canine Genetics, Health and Medicine;2021-06-02

3. Statins for primary prevention of cardiovascular disease: modelling guidelines and patient preferences based on an Irish cohort;British Journal of General Practice;2019-04-23

4. Why are statin prescribing guidelines for primary prevention not always followed in primary care?;British Journal of General Practice;2016-09-29

5. Macrophage Heterogeneity and Plasticity: Impact of Macrophage Biomarkers on Atherosclerosis;Scientifica;2015